Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 37 for “"IMiDs"”.
-
Immunomodulatory drugs (IMiDs) in multiple myeloma: mechanism of action and clinical implications
Immunomodulatory drugs (IMiDs) are a class of drugs, derived from the teratogenic compound thalidomide, that have made a major impact on treatment of many diseases, from multiple myeloma to assorted inflammatory diseases. From its dark beginnings as a teratogenic agent that caused phocomelia in …
-
Investigating the Autoimmune Basis of Poor Response to BCG Immunotherapy in Non-Muscle Invasive Bladder Cancer
… immune mediated inflammatory diseases (IMIDs) that may further alter systemic immune function. B-cells are increasingly recognized as important regulators of the bladder tumor microenvironment (TME), yet their role in BCG responses remains poorly defined. Atypical B cells (ABC), a …
-
Foundations for pro-resolution target discovery
… immunvermittelten entzündlichen Erkrankungen (IMIDs), wie der rheumatoiden Arthritis (RA), ist die Remission von Entzündungen entweder intrinsisch gestört oder wird durch eine übermäßige entzündliche und immunologische Reaktion auf körpereigene Strukturen aus dem Gleichgewicht gebracht, was die …
-
Pathogenetic mechanisms and therapeutic target discovery in chronic immune-mediated inflammatory diseases: insights into the role of the lymphatic system and drug repurposing strategies
… in immune-mediated inflammatory diseases (IMIDs), with a focus on the lymphatic system in inflammatory bowel disease (IBD) and on transcriptomics-driven drug repurposing across IMIDs. In the first part of this thesis, we investigated the role of lymphoid structures in IBD pathogenesis, …
-
Leveraging Real-World Data, Including the Electronic Health Record, to Fill in Clinical Knowledge Gaps in Treating Pregnant People
… with immune-mediated inflammatory diseases (IMIDs). The association between IMIDs and elevated risk of adverse pregnancy outcomes depended on the specific type of IMIDs and presence of comorbidities. Consequently, this dissertation introduces innovative approaches to aid in filling in the …
-
Targeting the Bone Marrow Microenvironment: Exploring Gremlin1’s Role in Myeloma-Associated Macrophages and Developing IMiD-Sensitive Murine Models of Myeloma
… a viable target for anti-myeloma monotherapy. IMiDs induce MM cell death, stimulate anti-tumour immune responses within the BM microenvironment, and have been proposed as a novel strategy for M2-to-M1 MAM repolarisation. However, their effects are challenging to model in mice due to lack of …
-
Functional analysis of oncogenic lesions in multiple myeloma with potential significance for refractory disease
… complex, a target of immunomodulatory drugs (IMiDs), were also functionally analyzed in the current study. Hotspot mutations and mutations found in IMiDs refractory patients were modelized in L363 cells and their role in IMiDs sensitivity was studied. CUL4B mutations were found not to be …
-
Characterization of Ubiquitin Ligase Targeting by Anticancer Sulfonamides
… is similar to that of immunomodulatory drugs (IMiDs), which recruit substrates to the closely related CRL4-CRBN E3 ubiquitin ligase for ubiquitination. Known for their roles in inhibiting embryonic development and cancer cell growth, IMiDs exert their pleiotropic effects by targeting a variety …
-
Investigation of the anticancer activity and mechanisms of zinc diethyldithiocarbamate in multiple myeloma
… options such as immunomodulatory drugs (IMiDs), proteasome inhibitors (PI), CAR-T therapy and antibody-based therapies have improved the prognosis of MM, all patients eventually relapse due to the presence and development of drug resistance. Therefore, the development of new drugs to meet …
-
A Methodology for Reliable Data Mining on Health Administrative Data: Case Studies on Pediatric Immune-Mediated Inflammatory Diseases in Ontario, Canada
… of immune-mediated inflammatory diseases (IMIDs) has increased worldwide. It has been identified that exposures to environmental factors early in life are associated with increased risk of these diseases. However, hypothesis-driven analyses do not always identify all risk or protective …
-
NOVEL SALL4 DEGRADER FOR CANCER TREATMENT
… The reported immunomodulatory imide drugs (IMiDs) can only degrade SALL4A, not SALL4B, and have no therapeutic effects in SALL4-mediated cancer cells. Further studies suggested that SALL4B is the dominant oncogenic isoform. In this work, a high-throughput screening of 50,000 small molecules …
-
A longitudinal single-cell therapeutic atlas of anti-tumour necrosis factor treatment in inflammatory bowel disease
… in immune-mediated inflammatory diseases (IMIDs) requires an understanding of how cellular networks change following therapy. I describe a therapeutic atlas for Crohn’s disease (CD) and ulcerative colitis (UC) following anti-tumour necrosis factor (TNF) therapy. Almost 1 million single-cell …
-
ELUCIDATING TRANSCRIPTIONAL ROLES OF SALL4 ISOFORMS IN SALL4HI HEPATOCELLULAR CARCINOMA
… Furthermore, SALL4A degradation caused by IMIDs (thalidomide, lenalidomide, pomalidomide) does not affect HCC survival. Here, evidence is provided that SALL4B and upregulated purine metabolism can be uniquely targeted to inhibit tumorigenic properties of HCC. The mechanism of SALL4 …
-
Modellierung klonaler Evolution beim Multiplen Myelom
… Anwendung von immunmodulatorischen Medikamenten (IMiDs) führt zu einer Ubiquitinierung des Transkriptionsfaktors IKZF1 durch die E3-Ubiquitin-Protein-Ligase (CRBN-CUL4). Durch Mutationen in IKZF1 kommt es zu Störungen in diesem Prozess und damit zu einer Überexpression von IKZF1. Dies wirkt sich …
-
Die Alloimmuntherapie beim rezidivierten Multiplen Myelom: Ergebnisse einer retrospektiven Analyse
… für den Patienten dar. Neue Therapeutika wie IMiDs und Antikörper ermöglichen Therapieerfolge, die bis dato nicht möglich schienen. Allerdings sind diese Erfolge regelhaft von kurzer Dauer, was den Wunsch nach einer potentiell kurativen Option noch verständlicher macht. Zudem verbleibt die …
-
A bump and hole approach to the development of selective degrons
… but not the wild type (WT) ZF. Traditional IMiDs, such as thalidomide, lenalidomide and pomalidomide, are unsuitable for target validation due to off-target degradation of transcription factors IKZF1 and IKZF3, as well as other endogenous proteins.</p> <p>A library of ‘bumped’ IMiD analogues …
-
Proximity-driven degrader development: insights from CRBN and a validated neo-substrate
… and western blotting. Using CRBN and IMiDs as an example, this approach effectively filters potential candidates or off-targets and has identified both novel and known substrates and regulatory complexes of E3 ligases, enhancing our understanding of targeted protein degradation. …
-
Funktionelle Analyse von patientenspezifischen Mutationen in IKZF1/3 als mögliche Resistenzmechanismen in der Therapie des refraktären und rezidivierten multiplen Myeloms
… und bei RRMM sind immunmodulierende Medikamente (IMiDs), wie Lenalidomid, eine bedeutende Therapieoption. Durch die Bindung von Lenalidomid an den CRL4CRBN Ligase Komplex entwickelt dieser eine modifizierte Substratspezifität: die Transkriptionsfaktoren IKZF1 (Ikaros) und IKZF3 (Aiolos) werden …
-
Eine späte, dritte Hochdosis-Chemotherapie als wirksame Rezidivbehandlung des fortgeschrittenen multiplen Myeloms
… neuer Therapieoptionen im Bereich von IMiDs, PIs und gänzlich neuer immuntherapeutischer Behandlungsansätze stellt dabei die Behandlung eines Myelom-Patienten im späten Krankheitsrezidiv nach Versagen von Lenalidomid und Bortezomib eine therapeutische Herausforderung dar. Daneben …
-
Investigating the production and secretion of PEPITEM, a regulator of leukocyte trafficking
… to immune-mediated inflammatory diseases (IMIDs). PEPITEM (PEPtide Inhibitor of TransEndothelial Migration) is an immuno-regulatory peptide secreted by adiponectin-stimulated B-cells and acts to suppress T-cell transendothelial migration. It is known that PEPITEM is derived from the parent …
Page 1 of 2